2627 — Ab&B Bio Tech Co JS Balance Sheet
0.000.00%
Last trade - 00:00- HK$17.00bn
- HK$17.88bn
- CNY259.61m
Annual balance sheet for Ab&B Bio Tech Co JS, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 77.6 | 132 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 88.4 | 305 |
| Total Inventory | ||
| Total Other Current Assets | ||
| Total Current Assets | 213 | 496 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 835 | 1,031 |
| Net Intangible Assets | ||
| Long Term Notes Receivable | ||
| Total Assets | 1,120 | 1,613 |
| Payable / Accrued | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 529 | 909 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 756 | 1,466 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 363 | 147 |
| Total Liabilities & Shareholders' Equity | 1,120 | 1,613 |
| Total Common Shares Outstanding |